PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies …
![Duchenne Muscular Dystrophy Clinical Trial](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-5726835.webp?resize=600%2C338&ssl=1)
![Duchenne Muscular Dystrophy Clinical Trial](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-photo-5726835.webp?resize=600%2C338&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies …
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced it …